Cargando…
Reversal of Cancer Multidrug Resistance (MDR) Mediated by ATP-Binding Cassette Transporter G2 (ABCG2) by AZ-628, a RAF Kinase Inhibitor
Overexpression of ABCG2 remains a major impediment to successful cancer treatment, because ABCG2 functions as an efflux pump of chemotherapeutic agents and causes clinical multidrug resistance (MDR). Therefore, it is important to uncover effective modulators to circumvent ABCG2-mediated MDR in cance...
Autores principales: | Wang, Jing-Quan, Teng, Qiu-Xu, Lei, Zi-Ning, Ji, Ning, Cui, Qingbin, Fu, Han, Lin, Lizhu, Yang, Dong-Hua, Fan, Ying-Fang, Chen, Zhe-Sheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7753047/ https://www.ncbi.nlm.nih.gov/pubmed/33364237 http://dx.doi.org/10.3389/fcell.2020.601400 |
Ejemplares similares
-
AZ32 Reverses ABCG2-Mediated Multidrug Resistance in Colorectal Cancer
por: Liu, Kun, et al.
Publicado: (2021) -
Venetoclax, a BCL-2 Inhibitor, Enhances the Efficacy of Chemotherapeutic Agents in Wild-Type ABCG2-Overexpression-Mediated MDR Cancer Cells
por: Wang, Jing-Quan, et al.
Publicado: (2020) -
Dual TTK/CLK2 inhibitor, CC‐671, selectively antagonizes ABCG2‐mediated multidrug resistance in lung cancer cells
por: Wu, Zhuo‐Xun, et al.
Publicado: (2020) -
Pharmacogenetic Aspects of the Interaction of AT1 Receptor Antagonists With ATP-Binding Cassette Transporter ABCG2
por: Ripperger, Anne, et al.
Publicado: (2018) -
The ATP binding cassette transporter, ABCG1, localizes to cortical actin filaments
por: Pandzic, Elvis, et al.
Publicado: (2017)